In Russia there is no threat of shortage of medicines, said the experts during the “round table” to discuss the introduction from 1 July 2020, the digital labelling of medicines.
Previously, the Association of manufacturers of medicines warned of possible disruptions in the supply of medicine to the population. The problem, according to them, can arise because under the new rules from 1 July to introduce medicines without labeling only upon receipt of permission of the interdepartmental Commission, wrote “Izvestia”.
“In respect of those products, which calls on the Russian market, we are quite calm, because we see the risks for the products, which for the last two years do to the Russian market have been reported,” – said the Director of Department of development of pharmaceutical and medical industry of Ministry of industry and trade of Russia Alexey Alekhin. He added that for most dosage forms in Russia created excess capacity.
For individual medications manufactured before October 1, it is possible to import on the decision of a special Commission. Permission will be given with a minimum of documents in electronic form, said the head of the Department of organization of state control of quality of medical products of Roszdravnadzor Alla Trapkova.
“At present, the healthcare system works enter into the public market, every day we are monitoring all drugs that come into circulation per day. I think that the results of coordination will allow to neutralize possible risks to pharmaceuticals, which will come into circulation,” said Trepkov.
The representative of Roszdravnadzor also noted that the customs service is directed clarification on the admission to Russia unpackaged products.
CEO CRPT, which is the operator of the GIS “Monitoring the movement of pharmaceuticals”, Dmitry Alkhazov said that after July 1, the highest activity in the system show foreign manufacturers. “70% of the load, which we now see and 70% of the action coming from infamy. It can not but rejoice, because it is a significant indicator. That is, the shortage of drugs we exactly expected. In infarma really work very efficient team of managers and engineers, and we are in fact implementing’ve seen,” said alhazov.